Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-25 @ 2:46 AM
NCT ID:
NCT00499733
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of epithelial solid tumors of any of the following sites or types:
* Lung (closed to accrual as of 4/2/2009)
* Renal
* Prostate
* Breast (closed to accrual as of 4/2/2009)
* Sarcoma (closed to accrual as of 4/2/2009)
* Colon (closed to accrual as of 4/2/2009)
* Liver(closed to accrual as of 4/2/2009)
* Pancreatic (closed to accrual as of 4/2/2009)
* Bone (closed to accrual as of 4/2/2009)
* Head and neck (closed to accrual as of 4/2/2009)
* Melanoma (closed to accrual as of 4/2/2009)
* Carcinoma of unknown primary (closed to accrual as of 4/2/2009)
* Advanced or metastatic disease
* Ineligible for or unwilling to undergo surgical resection
* Eligible for cryotherapy but not expected to be cured by cryotherapy alone
PATIENT CHARACTERISTICS:
* ECOG performance status 0-2
* Life expectancy \> 3 months
* Creatinine \< 2.5 mg/dL
* Platelet count \>75,000/mm³
* INR\< 1.5
* No known HIV positivity
* No active, uncontrolled infection
* Not pregnant
* Negative pregnancy test
* Women of childbearing potential must practice adequate contraception
* No debilitating medical or psychiatric illness that would preclude giving informed consent or receiving optimal treatment and follow-up
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00499733
Study Brief:
Protocol Section:
NCT00499733